Bisindole natural products: A vital source for the development of new anticancer drugs
Mengwei Xu1, Rui Peng1, Qing Min1
1School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, PR China; Hubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, Xianning Medical College, Hubei University of Science and Technology, Xianning, PR China.
Abstract:
Currently, the number of new cancer cases and deaths worldwide is increasing year on year. In addition to the requirement for cancer prevention, the top priority is still to seek the effective cure of cancer. In over a half century of constant exploration, increasing attention has been paid to the excellent anticancer activity of natural products, with more and more natural products isolated, identified and detected. For this study, the focus lies the natural products of bisindole, where two indole molecules are indirectly linked or directly polymerized, developing the diversity of structure and mechanism, accompanied with the better anticancer activity than monomers. There has been a long history of applying indirubin and vincristine in cancer treatment, verifying the anticancer effect of bisindoles. Vincribine, midostaurin and other anticancer drugs have also been developed and commercialized. In this paper, a review regarding the potential therapeutic effect of bisindole alkaloids extracted from various natural products was carried out, in which the progress made in research of 242 bisindole alkaloids for cancer treatment was introduced. These compounds may be applicable as medicinal products for clinical research in the future.
Insights
Bisindole alkaloids from natural products show potent anticancer activity. This review details 242 bisindoles, highlighting their potential for future cancer therapeutics and clinical research.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Global cancer incidence and mortality rates are rising, necessitating effective treatments.
- Natural products, particularly bisindoles, have demonstrated significant anticancer potential.
- Existing bisindole-derived drugs like vincristine and midostaurin validate their therapeutic value.
Purpose of the Study:
- To review the therapeutic potential of bisindole alkaloids from natural sources for cancer treatment.
- To summarize research progress on 242 bisindole alkaloids with anticancer properties.
Main Methods:
- Literature review of bisindole alkaloids and their anticancer activities.
- Analysis of structural diversity and mechanisms of action of bisindole compounds.
- Compilation of data on 242 identified bisindole alkaloids.
Main Results:
- Bisindoles exhibit enhanced anticancer activity compared to their monomeric indole units.
- A wide array of bisindole structures with diverse mechanisms of action have been identified.
- Established bisindole drugs confirm their clinical relevance in oncology.
Conclusions:
- Bisindole alkaloids represent a promising class of compounds for cancer therapy.
- Further research into these natural products could lead to novel clinical applications.
- The reviewed bisindoles hold potential for future drug development in oncology.
More Related Videos
07:30A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
Published on: January 21, 2020
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
